Insights on Investigations

457 total results. Page 1 of 19.

Investigations Blog
DOJ Warns That AI and Algorithmic Pricing Tools Can Trigger Criminal Antitrust Liability
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Sean A. Worley, John M. Hindley

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
DOJ Secures Record $550 Million Settlement Over Alleged Aluminum Duty Evasion Scheme
Jackson David Toof, Nadia Patel, Mario A. Torrico, Rebekkah R.N. Stoeckler

On May 12, the US Department of Justice (DOJ) announced that Perfectus Aluminum Inc., Perfectus Aluminum Acquisitions LLC, and four affiliated warehousing companies agreed to one of the highest customs fraud settlements ever: a $549.5 million resolution of civil False Claims Act (FCA) allegations that they knowingly evaded antidumping and countervailing duties (AD/CVD) on aluminum extrusions imported from China.

Investigations Blog
Cybersecurity Failures and Liability for Health Care Organizations: A New Enforcement Frontier
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Shoshana Golden, Roberto Martinez

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
DOJ Civil Division Launches FOCUS Initiative to Vet Data-Mining Whistleblowers
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Shoshana Golden, Meredith Gillespie

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
DOJ’s National Fraud Enforcement Division Announces Over $340 Million in Fraud Actions in One Week
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Meghan F. Hart, Meredith Gillespie

Headlines that Matter for Companies and Executives in Regulated Industries

Health Care Counsel Blog
Diagnostics and Laboratory Services: Enforcement Trends and Practical Safeguards
Hillary M. Stemple, Meredith Gillespie

Health care enforcement targeting diagnostic and laboratory services accelerated in 2025 and shows no signs of slowing down in 2026.

Investigations Blog
IBM to Pay $17 Million for Alleged Discriminatory DEI Practices
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Elizabeth Satarov, Meghan F. Hart

Headlines that Matter for Companies and Executives in Regulated Industries

Alerts
DOJ’s $17 Million False Claims Act Settlement With IBM: Proof-of-Concept for Potential DEI Whistleblower Suits
Kevin R. Pinkney, Cissy Jackson, Nadia Patel

On April 10, the US Department of Justice (DOJ) announced that International Business Machines Corporation (IBM) agreed to pay more than $17 million to resolve allegations that it violated the False Claims Act (FCA) by failing to comply with anti-discrimination requirements as set forth in Title VII of the Civil Rights Act of 1964.

News
CMS’s Latest Fraud Crackdown: A Q&A With Pat Naples
Pascal Naples

ArentFox Schiff’s Pat Naples discusses with Medical Economics the US Centers for Medicare & Medicaid Services’ (CMS) expanded anti‑fraud enforcement and its impact on health care providers.

Investigations Blog
White House Executive Order Establishes Fraud Task Force
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Elizabeth McLaughlin, Rebekkah R.N. Stoeckler

Headlines that Matter for Companies and Executives in Regulated Industries

Alerts
What Nonprofits Receiving Federal Funds Need to Know About the False Claims Act
Nadia Patel, Brian D. Schneider, Hannah Z. Shlaferman

The False Claims Act (FCA) is the single-most powerful tool for rooting out fraud against the US government, and any nonprofit that receives federal funds should ensure compliance is integrated into its programs to avoid the severe penalties that can come with FCA violations.

Investigations Blog
Third Circuit Hears Oral Arguments in $1.6 Billion Johnson & Johnson Appeal
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Meghan F. Hart, Elizabeth McLaughlin

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
DOJ Announces Corporate Enforcement and Voluntary Self-Disclosure Policy for All Criminal Cases
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Apeksha Vora, Meghan F. Hart

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
Pennsylvania Federal Court Blocks DOJ Subpoena for Transgender Patient Records
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Pascal Naples, Rebekkah R.N. Stoeckler

Headlines That Matter for Companies and Executives in Regulated Industries

Investigations Blog
Jury Finds Ex-NFL Player Turned Lab Owner Guilty of Genetic Testing Fraud Scheme
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Michelle J. Shapiro, Hillary M. Stemple, Laura Zell, Pascal Naples, John M. Hindley

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
Insurance Executives Sentenced to 20 Years for $233 Million ACA Enrollment Fraud Scheme
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, John M. Hindley, Sean A. Worley

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
New York Federal Court Dismisses False Claims Act Suit Against COVID-19 Testing Facility Company, Without Prejudice
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Roberto Martinez, Sean A. Worley

Headlines that Matter for Companies and Executives in Regulated Industries

Alerts
Takeaways From DOJ Fraud Section’s 2025 Year in Review
Michelle J. Shapiro, Alexander S. Birkhold, Elizabeth Satarov, Nardeen Billan, Elizabeth McLaughlin

On January 22, 2026, the US Department of Justice (DOJ) Criminal Division’s Fraud Section released its 2025 Year in Review (the Report), detailing its enforcement efforts and priorities.

Investigations Blog
DOJ Secures Conviction in $197 Million Health Care Fraud Scheme Targeting Seniors and Veterans
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Shoshana Golden, Roberto Martinez

Headlines that Matter for Companies and Executives in Regulated Industries

Events
Webinar: False Claims Act Enforcement Trends in the Health Care Industry
Hillary M. Stemple, Nadia Patel

False Claims Act Investigations Partners Hillary Stemple (Health Care) and Nadia Patel (Litigation) will host a Continuing Education webinar on recent trends in health care fraud enforcement for the Health Care Compliance Association on January 27, 2026.

Investigations Blog
DOJ False Claims Act Suit Targets Long Term Care Hospital Chain
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Shoshana Golden, Meredith Gillespie

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
DOJ Reports Record FY 2025 False Claims Act Recoveries Exceeding $6.8 Billion
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Heather M. Zimmer, Elizabeth Satarov

Headlines that Matter for Companies and Executives in Regulated Industries

Investigations Blog
Aerospace and Defense Contractor Resolves False Claims Act Allegations for $1.5 Million
D. Jacques Smith, Michael F. Dearington, Nadia Patel, Hillary M. Stemple, Laura Zell, Michelle J. Shapiro, Elizabeth Satarov, Apeksha Vora

Headlines that Matter for Companies and Executives in Regulated Industries

Alerts
False Claims Act Enforcement in 2026 to Focus on DEI, AI Fraud
D. Jacques Smith, Nadia Patel, Meghan F. Hart

The enforcement landscape entering 2026 points to sustained False Claims Act activity across traditional health care fraud, AI-enabled misconduct, civil rights–based claims, customs and tariff fraud, and expanding theories of investor liability.

Health Care Counsel Blog
AKS Hot Zone: Contract Sales Forces and the Limits of Incentive Pay
Hillary M. Stemple, Meredith Gillespie

For the past several years, the use of contract sales forces by pharmaceutical and device manufacturers and other suppliers has been under a heightened enforcement spotlight.